John Mac
Senior Member
- Messages
- 321
- Location
- Liverpool UK
The slow pace is extremely frustrating, I hear you there. I think there should be concurrent clinical trials with Rituximab and other drugs going on with this observational study. It's so hard to bootstrap research capacity. The Congressional action day coming up on May 17th in DC could help, but it's hard to get Congress to earmark funds and direct NIH to do certain things with such a small and scattered advocacy movement.
Let's hope some early results might persuade them to speed things up